Tumor-infiltrating B cells: Their dual mechanistic roles in the tumor microenvironment

被引:8
作者
Xue, Demin [1 ]
Hu, Shaozhen [2 ]
Zheng, Runchen [1 ]
Luo, Huidan [3 ]
Ren, Xi [4 ]
机构
[1] Chengdu Univ Tradit Chinese Med, Sch Chinese Class, Chengdu 611137, Peoples R China
[2] Guangzhou Univ Chinese Med, Sci & Technol Innovat Ctr, Guangzhou 510006, Peoples R China
[3] Hechi Hosp Tradit Chinese Med, Dept Pulmonol, Hechi 547000, Guangxi, Peoples R China
[4] Southern Med Univ, Southern Med Univ Hosp Integrated Tradit Chinese &, Dept Oncol 2, Guangzhou 510515, Peoples R China
关键词
Tumor-infiltrating B cells; Tumor microenvironment; Immune microenvironment; Immunotherapy; T-CELL; PLASMA-CELLS; ANTITUMOR IMMUNITY; BREAST-CANCER; LYMPHOCYTES; IMMUNOTHERAPY; ANTIGEN; RESPONSES; INFLAMMATION; CHEMOTHERAPY;
D O I
10.1016/j.biopha.2024.117436
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The occurrence and development of tumors are closely associated with abnormalities in the immune system's structure and function, with tumor immunotherapy being intricately linked to the tumor microenvironment (TME). Early studies on lymphocytes within the TME primarily concentrated on T cells. However, as research has advanced, the multifaceted roles of tumor-infiltrating B cells (TIL-Bs) in tumor immunity, encompassing both anti-tumor and pro-tumor effects, have garnered increasing attention. This paper explored the composition of the TME and the biological characteristics of TIL-Bs, investigating the dual roles within the TME to offer new insights and strategies for tumor immunotherapy.
引用
收藏
页数:10
相关论文
共 106 条
[1]   Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer [J].
Al-Shibli, Khalid I. ;
Donnem, Tom ;
Al-Saad, Samer ;
Persson, Magnus ;
Bremnes, Roy M. ;
Busund, Lill-Tove .
CLINICAL CANCER RESEARCH, 2008, 14 (16) :5220-5227
[2]   The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors [J].
不详 .
NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (12) :854-+
[3]   B-cell follicle development remodels the conduit system and allows soluble antigen delivery to follicular dendritic cells [J].
Bajenoff, Marc ;
Germain, Ronald N. .
BLOOD, 2009, 114 (24) :4989-4997
[4]   B cells extract and present immobilized antigen: implications for affinity discrimination [J].
Batista, FD ;
Neuberger, NS .
EMBO JOURNAL, 2000, 19 (04) :513-520
[5]   Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity [J].
Bhat, Purnima ;
Leggatt, Graham ;
Waterhouse, Nigel ;
Frazer, Ian H. .
CELL DEATH & DISEASE, 2017, 8 :e2836-e2836
[6]   Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137L [J].
Bodogai, Monica ;
Chang, Catalina Lee ;
Wejksza, Katarzyna ;
Lai, Jinping ;
Merino, Maria ;
Wersto, Robert P. ;
Gress, Ronald E. ;
Chan, Andrew C. ;
Hesdorffer, Charles ;
Biragyn, Arya .
CANCER RESEARCH, 2013, 73 (07) :2127-2138
[7]   Plasma cells in primary melanoma. Prognostic significance and possible role of IgA [J].
Bosisio, Francesca M. ;
Wilmott, James S. ;
Volders, Nathalie ;
Mercier, Marjorie ;
Wouters, Jasper ;
Stas, Marguerite ;
Blokx, Willeke A. M. ;
Massi, Daniela ;
Thompson, John F. ;
Scolyer, Richard A. ;
van Baren, Nicolas ;
van den Oord, Joost J. .
MODERN PATHOLOGY, 2016, 29 (04) :347-358
[8]   Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].
Bray, Freddie ;
Laversanne, Mathieu ;
Sung, Hyuna ;
Ferlay, Jacques ;
Siegel, Rebecca L. ;
Soerjomataram, Isabelle ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2024, 74 (03) :229-263
[9]   Tumor-infiltrating B cells producing antitumor active immunoglobulins in resected HCC prolong patient survival [J].
Brunner, Stefan M. ;
Itzel, Timo ;
Rubner, Christoph ;
Kesselring, Rebecca ;
Griesshammer, Eva ;
Evert, Matthias ;
Teufel, Andreas ;
Schlitt, Hans J. ;
Fichtner-Feigl, Stefan .
ONCOTARGET, 2017, 8 (41) :71002-71011
[10]   Targeting B cell receptor signalling in cancer: preclinical and clinical advances [J].
Burger, Jan A. ;
Wiestner, Adrian .
NATURE REVIEWS CANCER, 2018, 18 (03) :148-167